ClinVar Miner

Submissions for variant NM_001126112.2(TP53):c.214_215delinsTG (p.Pro72Cys) (rs730882014)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen TP53 Variant Curation Expert Panel,ClinGen RCV000410841 SCV001737948 uncertain significance Li-Fraumeni syndrome 1 2021-04-12 reviewed by expert panel curation his variant is absent in the gnomAD cohort (PM2_Supporting; This variant has been observed in 4 60+ year old females without a cancer diagnosis (BS2_Supporting; internal laboratory contributors). In summary, the clinical significance of TP53 c.214_215delinsTG (p.Pro72Cys) is uncertain for Li-Fraumeni syndrome. ACMG/AMP criteria applied, as specified by the TP53 Variant Curation Expert Panel: BS2_Supporting, PM2_Supporting.
GeneDx RCV000587915 SCV000211787 uncertain significance not provided 2020-09-16 criteria provided, single submitter clinical testing Located in the critical SH3 domain (Bode 2004) Not observed at a significant frequency in large population cohorts (Lek et al., 2016) In silico analysis supports that this missense variant does not alter protein structure/function Published functional studies demonstrate retention of growth suppression activity and no dominant-negative effect (Giacomelli 2018)
Ambry Genetics RCV000161055 SCV000215338 likely benign Hereditary cancer-predisposing syndrome 2019-12-11 criteria provided, single submitter clinical testing Insufficient or conflicting evidence
Counsyl RCV000410841 SCV000488534 uncertain significance Li-Fraumeni syndrome 1 2016-04-20 criteria provided, single submitter clinical testing
Invitae RCV000554325 SCV000629788 uncertain significance Li-Fraumeni syndrome 2020-09-08 criteria provided, single submitter clinical testing This sequence change replaces proline with cysteine at codon 72 of the TP53 protein (p.Pro72Cys). The proline residue is moderately conserved and there is a large physicochemical difference between proline and cysteine. This variant is reported as two separate single-nucleotide changes in the ExAC database (c.214C>T and c.215C>G), but the read data shows that the two variants are in cis, recapitulating the variant observed here (c.214_215delCCinsTG), in one individual. This variant has not been reported in the literature in individuals with TP53-related disease. ClinVar contains an entry for this variant (Variation ID: 182953). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: Deleterious; PolyPhen-2: Benign; Align-GVGD: Class 0). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Color Health, Inc RCV000161055 SCV000686727 uncertain significance Hereditary cancer-predisposing syndrome 2020-01-25 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000587915 SCV000697436 uncertain significance not provided 2016-03-14 criteria provided, single submitter clinical testing Variant summary: The c.214_215delinsTG variant affects two nucleotides, resulting in amino acid change from Pro to Cys. One in-silico tool predicts benign outcome for this variant. This variant is not found in 120958 control chromosomes. In addition, multiple clinical laboratories/reputable database classified this variant as VUS. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical laboratories; nor evaluated for functional impact by in vivo/vitro studies. Because of the absence of clinical information and the lack of functional studies, the variant was classified as a variant of uncertain significance (VUS) until additional information becomes available.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.